It is well established that failure of the lamellar basement membrane (BM) occurs during the development of equine laminitis. This is due to loss of the crucial BM components; laminins and collagens along with loss of attachment complex, the hemidesmosome, of the basal cell to the underlying BM. Previous studies have suggested that Ln-332 may be the primary protein involved in lamellar failure. However, the details of the progression and mechanism involved in this pathology are not currently fully known. This thesis aimed to refine the proteolytic processes and mechanisms occurring during the development of oligofructose induced laminitis. Through the use of novel temporal lamellar biopsies obtained during the development of laminitis induction, it was determined that loss of both Ln-332 and collagen type IV occurs as early as 12 hours post induction. This loss of reactivity initially occurred in a focal pattern with increasing loss as the disease progressed in severity. At the later stages of laminitis, separation of the basal epithelial cell from the dermal tissue was also observed, however at these points the BM still appeared intact. This suggests that more than one mechanism may be involved in disease pathology; one resulting in fragmentation of the BM while a second results in loss of the cell attachment allowing the intact BM to slip away. Immunohistochemical analysis of lamellar tissue revealed a unique pattern of reactivity for the Ln-332 γ2 antibody D4B5, in which no reactivity was observed in normal lamellar tissue, yet the epitope recognized by this antibody becomes apparent during disease development. This initially led to the hypothesis that cleavage of the γ2 subunit and the release of biologically active fragments may occur. However, at the molecular level, no γ2 fragments were detected by western blotting. In vitro cleavage of partially purified equine Ln-332 revealed that both MMP-2 and MT1-MMP were able to process the molecule to produce fragments corresponding to the biologically active counterparts. This suggests that the change in reactivity with this antibody may be due to other mechanisms such as decreased interaction of Ln-332 with other BM components resulting in loss of structural stability of the BM allowing for a change in the orientation of Ln-332. Increased MMP-2, MMP-9 and MT1-MMP expression has been demonstrated in laminitis and this was assumed to be the causative agent resulting in tissue destruction and failure. However, work in this thesis found no increase in gene expression of MMP- 2 and MT1-MMP, as well as no activation of pro MT1-MMP. Increased pro MMP-9 gene and protein expression was observed early in the disease progression yet no MMP- 9 activation occurred. Additionally, activation of MMP-2 was found to occur late in laminitis progression at least 12 hours following BM degradation, thus MMP-2 activation is a secondary effect of laminitis development. Thus, other proteases are expected to result in BM processing. Gene expression of the metalloprotease ADAMTS-4, was observed to increase early during laminitis development, suggesting this is a putative factor involved in intensifying the degradation of the lamellar BM. Work in this thesis also revealed that both Ln-332 and collagen type IV are widely distributed throughout organs in the equine body and localized primarily to BM structures. A novel finding of this thesis is that not only does BM degradation occur in the lamellar BM, it also occurs in organs remote from the hoof. At both the onset of lameness and the acute phase of laminitis, fragmentation of both Ln-332 and collagen type IV also occurs in both the skin and stomach. Recent studies have indicated that both leukocyte emigration and increased cytokine expression occurs in the lamellar tissue during laminitis. Work in this thesis added to this knowledge as leukocyte infiltration into the lamellar tissue occurs early during oligofructose laminitis induction as does increased IL-6 gene expression. Overall, work conducted in this thesis has added to the knowledge of the events occurring during laminitis development. Even though the complete mechanism of tissue destruction and lamellar failure was not established, the progression of events is now more clear in that BM degradation is one of the first events to occur, while MMP-2 activation occurs secondarily. Thus, other mechanisms must be at work early during laminitis development and discovering what they are must remain a research priority for the realization of effective therapeutic strategies.

Thesis (M.S.)--University of Michigan, 1967.

Thesis (M.S.)--University of Southern California, 1999. / eContent provider-neutral record in process. Description based on print version record. Includes bibliographical references.

Thesis (M.S.)--University of Michigan, 1967.

Abstract This study was initiated to elucidate the complete genomic structures of type XV collagen in man and mouse and the functional properties of their promoters, as well as to obtain knowledge of the biological role of type XV collagen during development and maturity using immunofluorescence and transgenic techniques. The cloning and characterization of genomic clones revealed that the human COL15A1 gene is 145-kb in size and consists of 42 exons, and the mouse Col15a1 gene is 110-kb with 40 exons. The genomic organization of the two genes was found to be highly conserved, except for two regions of divergence. The nuclease S1 protection analysis revealed multiple transcription initiation sites in both genes, which is in accordance with the overall genomic structures of their 5'-flanking sequences. Transient cell transfection experiments with varying lengths of 5'-deletion constructs identified the fragments necessary for basic promoter activity in both genes and those implicated in the positive and negative regulation of the mouse Col15a1 gene. Furthermore, the involvement of transcription factor Sp1 in the gene regulation of the human COL15A1 gene was demonstrated. A mouse specific polyclonal antibody against type XV collagen was generated and utilized in the localization of type XV collagen protein in developing and mature mouse tissues. Type XV collagen was deposited early in the development and was particularly prominent in capillaries. Spatio-temporal differences in the expression of type XV collagen in various capillary types was demonstrated. Early expression was also detected in the skeletal muscle and peripheral nerves, while expression in the heart, lung, and kidney appeared to be developmentally regulated. Transgenic mice lines expressing truncated type XV collagen driven by either short or long endogenous type XV collagen promoters were generated. The two promoters conferred different tissue-specificities and expression levels, the longer one resulting in more endogenous-like expression. Despite some expression at both mRNA and protein levels, the truncated type XV collagen did not cause any obvious phenotypic or histological changes in any of the lines driven by the shorter promoter fragment. In heterozygote matings of one of the lines driven by the longer promoter fragment, however, a portion of the transgene positive mice appeared to be lost prenatally. Furthermore, pregnancy terminations in this line indicated a high number of abortions beginning at about 11 days of development. Further studies are needed before detailed conclusions on the consequences of the generated mutation can be drawn. The elucidation of the genomic structure of the human COL15A1 gene provides the necessary database for screening mutations in patient samples for candidate diseases caused by this collagen. The genomic clones and the mouse-specific antibody against type XV collagen are valuable tools also in future projects. The knowledge of the developmental dynamics of type XV collagen is of great value, as it helps to understand the physiological consequences that the as yet unidentified mutations in type XV collagen may cause in humans.

Abstract In this work the type XVIII collagen has been studied by using several approaches, such as different animal models. The primary structure of frog, Xenopus laevis, type XVIII collagen and the expression pattern of its variants during early embryogenesis have been elucidated. The gene structure of human type XVIII collagen was characterized and the localization and processing of its longest variant was studied by generated antibodies. In addition, the function of the proteolytically released C-terminal part of type XVIII collagen, endostatin, was studied by generating transgenic mice expressing endostatin. The primary structure of X. laevis type XVIII collagen is comprised of three N-terminal variants resembling their mammalian counterparts. The sizes of the polypeptides are 1285, 1581, and 1886 residues. The most conserved regions are the C-terminal endostatin region and the cysteine-rich domain in the N-terminus. Whole-mount in situ hybridization reveals different expression patterns for variants during embryogenesis. The short variant is the most abundant, whereas the two longest variants exhibit more restricted expression. The gene structure of human type XVIII collagen reveals an exon-intron organization that is conserved with mouse. The length of the human gene is about 105 kb and contains 43 exons. The third variant of type XVIII collagen has a conserved cysteine-rich domain with homology to the extracellular part of frizzled proteins. This third variant is localized to developing muscle and lung, and is also found in serum. In cell culture, the proteolytic fragments of the N-terminus, including the cysteine-rich motif, are also detected. Endostatin function was studied by generating mouse lines expressing endostatin under the keratin-14 promoter, which drives the expression mainly in the skin. Three independent transgenic mouse lines were achieved with varied expression levels. The phenotype was seen in the eye with lens opacity and abnormal morphology of epithelial cells in the lens. In the skin, a broading of the basement membrane in the epidermis dermis junction was detected. Immunoelectron microscopy analysis revealed a polarized orientation of type XVIII collagen in the basement membrane. In transgenic mice, altered localization of endogenous type XVIII collagen was seen, suggesting displacement of the endogenous type XVIII collagen with transgenic endostatin leading to disorganized basement membrane.

Abstract Lysyl hydroxylase (LH, EC 1.14.11.4) catalyzes the post-translational hydroxylation of lysyl residues in collagens and other proteins with collagenous domains. The hydroxylysyl residues participate in the formation of collagen cross-links, and some of the hydroxylysyl residues are further glycosylated. Three lysyl hydroxylase isoforms LH1, LH2 and LH3, encoded by three individual genes have been characterized and one isoform, LH3 is a multifunctional enzyme containing lysyl hydroxylase, collagen galactosyltransferase (GT, E.C. 2.4.1.50) and glucosyltransferase (GGT, E.C. 2.4.1.66) activities in vitro. In this thesis the genes for the mouse lysyl hydroxylases were each mapped to a different chromosome. In addition, the roles of the lysyl hydroxylase isoforms were characterized in mice by studying their expression during development and the distribution of LH2 and LH3 in adult mice. The results revealed a widespread expression of the mouse lysyl hydroxylases during embryonic development whereas LH2 and LH3 showed tissue- or cell-specific expression patterns in the adult. Alternative splicing of the gene for LH2 also showed developmental and tissue-specific regulation. The different functions of LH3 were studied in vivo by generating three different LH3 manipulated mouse lines. Analysis of the mouse lines revealed that LH3 has lysyl hydroxylase and glucosyltransferase activities in vivo, and that, in particular, the glucosyltransferase activity of LH3 is essential for normal development. The loss of glucosyltransferase activity caused disruption of basement membranes leading to embryonic lethality while the absence of lysyl hydroxylase activity led to ultrastructural alterations in muscle and basement membranes and disorganization of collagen fibrils. The disruption of basement membrane was due to an intracellular accumulation of unglycosylated type IV collagen, whereas the ultrastructural alterations were related to the abnormal aggregation and distribution of underglycosylated type VI collagen. The results demonstrate that hydroxylysine-linked glycosylations are critical for the secretion of type IV collagen and its assembly into basement membranes, and for the assembly and distribution of type VI collagen.

The signalling cascade induced by the binding of neurotrophins (NGF, BDNF, NT3 and NT4) to their high-affinity tyrosine kinase receptors (TrkA, B and C) is well documented to be important for neuronal cell survival, proliferation and differentiation. Evidence has accumulated demonstrating the importance of these signalling pathways in nonneuronal tissues, including the ovary where all neurotrophins and their receptors are expressed. In the mouse, effects on ovulation have been demonstrated but the role of Trk signalling in neonatal ovary development is less clear. Previous work had found that TrkB expression is upregulated at the time of follicle formation in the mouse and transgenic mice null for the TrkB receptor demonstrate significant loss of oocytes neonatally (TrkB knockouts, KO, die shortly after birth). This thesis examines the phenotype of the TrkB KO using morphological, histological and surgical techniques with the aim being to further investigate the role of TrkB signalling in oocyte survival, and to contribute to our understanding of neonatal ovary development. The main questions addressed are: 1) what developmental defects are occurring on a morphological level that result in the phenotype of the TrkB KO; 2) can these defects be quantified; and 3) what are the longterm survival prospects for TrkB KO oocytes. Morphological assessment revealed that TrkB KO ovaries exhibit poorer follicle health than their Controls and this was confirmed by assessment of basement membrane (BM) composition. TrkB KO brain and kidney were also assessed and found to have similarly affected BM. It is well known that cells require contact with the BM to maintain survival, thus it is postulated that TrkB signalling contributes to oocyte survival through regulation of the BM. Due to the postnatal lethality of the mutation, TrkB KO ovaries were transplanted to ascertain long-term oocyte survival. Unexpectedly it was found that TrkB KO oocytes are able to survive and follicles grow as well as they do in the Control transplants. Consequently, the in vivo effect has to be indirect. It is known that oocytes in the neonatal ovary undergo an increased rate of cell death but it is not known how the cell debris is removed. A novel observation of a neonatal ovarian immune response has been made in this thesis and is postulated to be a physiological mechanism for cell debris clearance. In conclusion, this thesis has demonstrated that signalling through TrkB has an effect on regulating BM in the ovary and other organs, but that surprisingly it has an indirect effect on oocyte survival.

Le mélanome est le cancer cutané le plus invasif. Au cours de l’invasion tumorale et de la dissémination métastatique, les cellules tumorales sont capables de dégrader la matrice extracellulaire par la sécrétion de protéases telles que les MMPs. Lors de cette protéolyse matricielle, différents fragments de la matrice extracellulaire exerçant des activités anti-tumorale et/ou anti-angiogénique, nommés matrikines, sont libérés et modulent la croissance tumorale. De nombreuses matrikines dérivées des collagènes de membrane basale sont capables de limiter la progression tumorale. Nous avons étudié les propriétés anti-tumorales du domaine NC1 α4(IV), nommé tétrastatine, à la fois in vitro et in vivo dans un modèle de mélanome humain. La tétrastatine induit une inhibition de la prolifération et de l’invasion des cellules de mélanome in vitro. L’inhibition de prolifération est corrélée à un retard en phase G1/S du cycle cellulaire en présence de tétrastatine. L’inhibtion de l’invasion peut notamment s’expliquer par une inhibition de l’activation de la MMP-14 et une modification de sa répartition cellulaire, avec perte du phénotype migratoire en présence de tétrastatine. In vivo, la surexpression de la tétrastatine induit une forte inhibition de la croissance tumorale, dans un modèle de xénogreffe de mélanome humain chez la souris nude. Nous avons également pu identifier l’intégrine αvβ3 comme un récepteur potentiel de la tétrastatine. Enfin, l’étude des capacités anti-prolifératives et anti-invasives des cellules UACC 903 en présence de différents peptides permet aujourd’hui de mieux préciser la séquence responsable de l’activité anti-tumorale de ce domaine. En conclusion, la tétrastatine est une nouvelle matrikine à fort potentiel anti-tumoral capable de limiter la progression du mélanome. / Melanoma is the most invasive cutaneous cancer. During tumor invasion and metastatic dissemination, tumor cells degrade the extracellular matrix by secretion of proteases such as MMPs. During matrix proteolysis, fragments of the extracellular matrix with anti-tumor and/or anti-angiogenic activities, called matrikines, are released and modulate tumor growth. Many matrikines derived from basement membrane collagens are able to inhibit tumor progression. We studied the anti-tumor properties of the domain NC1 α4 (IV), named tetrastatin, both in vitro and in vivo in a human melanoma model. Tetrastatin induces inhibition of proliferation and invasion of melanoma cells in vitro. This inhibition of proliferation is correlated to a cell cycle delay in G1/S phase when cells are incubated with tetrastatin. The inhibition of invasion could be due, at least partly, to the inhibition of MMP-14 active form and modification of its cellular distribution, with a loss of the migratory phenotype in the presence of tetrastatin. In vivo, tetrastatin overexpression induces a strong inhibition of tumor growth, in a human melanoma xenograft model in nude mice. We also identified integrin αvβ3 as a potential receptor of tetrastatin. Finally, the study of the anti-proliferative and anti-invasive properties of the UACC 903 cells in the presence of different peptides allows us to better identify the sequence responsible of the anti-tumor activity. In conclusion, tetrastatin is a new potent anti-tumor matrikine capable of limiting melanoma progression.

Le vieillissement cutané s'accompagne d'altérations des composants de la matrice extracellulaire. Des études ont montré que le contenu en collagène IV diminuait dans la peau à partir de 35 ans. Le collagène IV, constituant majeur des membranes basales, est formé de l'association, en triple hélice, de 3 chaînes alpha parmi 6 possibles: alpha1(IV) à alpha6(IV). Au niveau de la membrane basale cutanée, encore appelée jonction dermo-épidermique, seulement deux isoformes de collagène IV ont été mises en évidence : [alpha1(IV)2; alpha2(IV)], isoforme majoritaire, et [alpha5(IV)2; alpha6(IV)], isoforme minoritaire, synthétisées par les fibroblastes et les kératinocytes. Nous avons vérifié, par western-blot sur des extraits de peaux, cette diminution de collagène IV. Nous avons ensuite analysé la répartition du collagène IV au niveau de la JDE sur des coupes transversales de peau et n'avons pu mettre en évidence de discontinuité dans le réseau de collagène IV avec l'âge, du fait des fortes variations inter-individuelles. Parallèlement, sur coupe de peau, nous avons tenté de mettre en évidence des différences spectrales du collagène IV avec l'âge par spectroscopie Raman mais la résolution s'est avérée insuffisante. Nous avons isolé des fibroblastes de patients d'âges différents et montré une diminution de l'expression génique de la chaîne alpha1(IV) malgré de fortes variations inter-individuelles. Afin de s'affranchir de ces variations inter-individuelles pour étudier les mécanismes impliqués dans la diminution d'expression du collagène IV, nous avons mis au point un modèle de vieillissement accéléré de fibroblastes traités à l'H2O2 et vérifié le phénotype sénescent des cellules (morphologie modifiée, augmentation de l'activité SA-beta-galactosidase, augmentation de p21WAF-1…). Nous nous sommes intéressé à la voie du TGF-beta1. Nous avons montré que l'expression du récepteur au TGF-beta1, TbetaRII, diminuait dans le modèle de vieillissement accéléré. Nous avons également montré qu'un anticorps bloquant anti-TGF-beta1 reproduisait la diminution d'expression de collagène IV observée au cours de la sénescence. La détermination du mécanisme impliqué pourrait permettre, à terme, de proposer de nouvelles stratégies pour maintenir l'intégrité de la membrane basale lors du vieillissement cutané. / During aging skin there are extracellular matrix alterations. Preliminary studies showed that type IV collagen content decreased in skin with age after 35 years. Type IV collagen is a major component of basement membranes. It's constituted by the association of 3 alpha chains among 6 possible (alpha1 to alpha6). In the cutaneous basement membrane also called dermo-epidermal junction, only two isoform of type IV collagen were found: [alpha1(IV)2; alpha2(IV)], which is majoritary isoform, and [alpha5(IV)2; alpha6(IV)], which is minoritary, both synthesized by fibroblasts and keratinocytes. We checked the decrease in type IV collagen by western-blot on skin extracts. We then analyzed the distribution of this collagen in the DEJ on skin sections but we were not able to highlight a discontinuity in the network of type IV collagen during aging. At the same time, we tried to highlight spectral differences of the collagen IV with aging by Raman spectroscopy on skin sections but the resolution was insufficient. 35 years. We showed a decrease of type IV collagen expression by dermal fibroblasts in spite of strong variation between patients. In order to study the mechanism involved in type IV collagen variation during aging in dermal fibroblasts avoiding inter-individual variations, we develop an accelerated aging model of fibroblasts by treatment with H2O2. We checked the senescent phenotype of the cells (modified morphology, increase of SA-beta-galactosidase activity, increase of p21WAF-1…). We were interested on the TGF-1 pathway and we showed that TGF-beta1 receptor, called TbetaRII, was decreased in our accelerated aging model. We also showed that a blocking antibody against TGF-beta1 reproduced the decrease of type IV collagen expression observed during the senescence. The determination of the involved mechanism could lead to propose new strategies to maintain the integrity of the basal membrane during skin aging.